Ozempic and similar drugs could interfere with common medical procedure, research warns A new study reveals that GLP-1 drugs may affect medical scan results, though experts say findings are preliminary and more data is needed before changing medical practice.
Ex-Red Sox star Mike Greenwell dead at 62 after cancer battle Mike Greenwell, a two-time All-Star with the Boston Red Sox who got into public service after his career was over, has died after a battle with thyroid cancer. He was 62.
Prostate cancer patients see longer survival with new combination drug A UCLA study shows that a new treatment combining a radioactive drug with radiation therapy could help delay hormone therapy for men with recurring prostate cancer.
Risk of deadly cancer triples with hidden mouth bacteria, study finds Scientists link poor oral health to dramatically higher pancreatic cancer risk, emphasizing the importance of regular brushing and dental care for prevention.
New breast cancer drug wins FDA approval after slashing progression risk by nearly 40% The FDA-approved Inluriyo, an oral estrogen receptor antagonist from Eli Lilly, has shown to achieve significant improvement in progression-free survival for breast cancer.
Mother of pediatric cancer survivor expresses optimism for Trump’s AI research order Kathryn Armstrong, the mother of cancer survivor Laurel, discusses her daughter’s experience fighting the deadly disease and the potential impact of President Donald Trump’s AI pediatric research executive order on ‘Fox & Friends.’
Trump signs executive order to harness AI in fight against childhood cancers President Donald Trump signed an executive order aiming to use artificial intelligence to improve pediatric cancer diagnosis and treatment, with $50 million in funding.
Trump addresses pediatric cancer treatment advancements in executive order signing President Donald Trump signs an executive order boosting childhood cancer research and the administration speaks on lowering drug prices.
Weight-loss drugs now linked to cancer protection in women, major new study reveals A new study finds that GLP-1 medications are linked to lower overall cancer risk, particularly for endometrial and ovarian cancers, in obese adults. Oncologist Dr. Slomovitz discusses the findings.
Oncology director shares how GLP-1s can help protect against cancer Dr. Brian Slomovitz, director of gynecologic oncology at Mount Sinai Medical Center in Miami Beach, Florida, says the link between GLP-1 and reduced cancer risk is "not surprising."
